van der Mooren MJ - Search Results

1

Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: two randomized, placebo-controlled, 2-year studies.

Vogelvang TE, Mijatovic V, Kamp O, Netelenbos JC, Neele SJ, Pines A, Kenemans P, van der Mooren MJ. Vogelvang TE, et al. Among authors: van der mooren mj. Am J Obstet Gynecol. 2002 Apr;186(4):729-36. doi: 10.1067/mob.2002.122092. Am J Obstet Gynecol. 2002. PMID: 11967499 Clinical Trial.

2

Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women.

Vogelvang TE, van der Mooren MJ, Mijatovic V, Kenemans P. Vogelvang TE, et al. Among authors: van der mooren mj. Drugs. 2006;66(2):191-221. doi: 10.2165/00003495-200666020-00005. Drugs. 2006. PMID: 16451093 Review.

3

A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine.

Smolders RG, Vogelvang TE, Mijatovic V, van Baal WM, Neele SJ, Netelenbos JC, Kenemans P, van der Mooren MJ. Smolders RG, et al. Among authors: van baal wm, van der mooren mj. Maturitas. 2002 Feb 26;41(2):105-14. doi: 10.1016/s0378-5122(01)00280-8. Maturitas. 2002. PMID: 11836041 Clinical Trial.

4

Effects of oral and transdermal low-dose estrogen therapy on echocardiographic parameters of cardiac function.

Vogelvang TE, van der Mooren MJ, Kamp O, Mijatovic V, Visser CA, Kenemans P. Vogelvang TE, et al. Among authors: van der mooren mj. Fertil Steril. 2003 Sep;80(3):546-53. doi: 10.1016/s0015-0282(03)00754-4. Fertil Steril. 2003. PMID: 12969696 Free article. Clinical Trial.

5

Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.

Hemelaar M, van der Mooren MJ, Mijatovic V, Bouman AA, Schijf CP, Kroeks MV, Franke HR, Kenemans P. Hemelaar M, et al. Among authors: van der mooren mj. Menopause. 2003 Nov-Dec;10(6):550-8. doi: 10.1097/01.GME.0000064866.58809.E5. Menopause. 2003. PMID: 14627865 Clinical Trial.

6

Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study.

Post MS, van der Mooren MJ, van Baal WM, Blankenstein MA, Merkus HM, Kroeks MV, Franke HR, Kenemans P, Stehouwer CD. Post MS, et al. Among authors: van der mooren mj, van baal wm. Am J Obstet Gynecol. 2003 Nov;189(5):1221-7. doi: 10.1067/s0002-9378(03)00599-4. Am J Obstet Gynecol. 2003. PMID: 14634544 Clinical Trial.

7

Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women.

Vogelvang TE, Leurs JR, van der Mooren MJ, Mijatovic V, Hendriks DF, Neele SJ, Netelenbos JC, Kenemans P. Vogelvang TE, et al. Among authors: van der mooren mj. Menopause. 2004 Jan-Feb;11(1):110-5. doi: 10.1097/01.GME.0000097740.18446.77. Menopause. 2004. PMID: 14716191 Clinical Trial.

8

Effect of HMR 3339, a novel selective estrogen receptor modulator, on C-reactive protein levels in healthy postmenopausal women.

Vogelvang TE, Mijatovic V, Kenemans P, Schalkwijk CG, van der Mooren MJ. Vogelvang TE, et al. Among authors: van der mooren mj. Am J Cardiol. 2004 Nov 1;94(9):1205-8. doi: 10.1016/j.amjcard.2004.07.099. Am J Cardiol. 2004. PMID: 15518626 Clinical Trial.

9

HMR 3339, a novel selective estrogen receptor modulator, reduces total cholesterol, low-density lipoprotein cholesterol, and homocysteine in healthy postmenopausal women.

Vogelvang TE, Mijatovic V, Kenemans P, Teerlink T, van der Mooren MJ. Vogelvang TE, et al. Among authors: van der mooren mj. Fertil Steril. 2004 Dec;82(6):1540-9. doi: 10.1016/j.fertnstert.2004.05.093. Fertil Steril. 2004. PMID: 15589857 Free article. Clinical Trial.

10

Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.

Vogelvang TE, van der Mooren MJ, Mijatovic V. Vogelvang TE, et al. Among authors: van der mooren mj. Treat Endocrinol. 2004;3(2):105-15. doi: 10.2165/00024677-200403020-00005. Treat Endocrinol. 2004. PMID: 15743106 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page